Multiple Myeloma: GPRC5D-Targeted Therapies for Relapsed/Refractory Multiple Myeloma

Moderated by Dr. Matthew Pianko

During this conversation, we will explore two cases, one CAR-T eligible patient with multiple prior therapies and one older patient with multiple prior therapies.

Interested in joining the virtual Targeted Oncology™ Case-Based Roundtable® ? Don't delay, virtual seating is limited to 14 participants!

To be eligible to attend this meeting, physicians must be practicing medical oncologists or hematologists treating patients for the specified tumor type and located within the event region.

Please note that fellows are not eligible to attend this meeting unless otherwise specified.

CASE-BASED ROUNDTABLE DETAILS

DATE & TIME

Monday, October 20, 2025
7:00 PM - 8:30 PM ET

EVENT REGION

Michigan & Illinois

Moderator

Join Targeted Oncology for a collaborative, small-group meeting designed around case-based clinical profiles and peer-dialogue led by an expert physician. This session offers practicing oncologists the perfect opportunity to sharpen their skills and expertise in treatment strategies.

Matthew Pianko, MD

Assistant Professor

University of Michigan

MARKET RESEARCH PARTICIPATION

This event is held in partnership with Healthcare Research & Analytics to gain market research insights into health care professional’s educational needs in their current practice setting.

HRA® offers compensation of $500 to oncologists for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.

Targeted Healthcare Communications^®— an MJH Life Sciences^® Brand

259 Prospect Plains Rd., Building H, Monroe, NJ 08831

Terms & Conditions

Do Not Sell My Info